Saturday, April 1, 2023
No Result
View All Result
  • Media
Support Us
Macdonald-Laurier Institute
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
    • Women’s History Month Fundraiser
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Annual Reports
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
    • Women’s History Month Fundraiser
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Annual Reports
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media
No Result
View All Result
Macdonald-Laurier Institute

COVID-19, other rare disorders and the rescue principle: Nigel Rawson and John Adams for Inside Policy

April 6, 2020
in Columns, COVID-19, Domestic Policy Program, Health, Inside Policy, Latest News
Reading Time: 3 mins read
A A

Lower ceiling prices for new medicines will make Canada less attractive as a country for new drugs and vaccines, making access to new drugs for Canadians with rare disorders even more challenging, writes Nigel Rawson and John Adams. 

By Nigel Rawson and John Adams, April 6, 2020

Given the impact of the COVID-19 pandemic on all aspects of Canadian life for the past several weeks, most Canadians would likely be very surprised if you told them that as of April 6, COVID-19 still qualified as a rare disease in Canada. Health Canada defines a rare disorder as one with a prevalence of not more than 5 in 10,000 persons that is life-threatening or seriously debilitating. So, COVID-19 becomes a common disease when 19,000 Canadians have it. It will finally cross that threshold this week.

COVID-19 causes fear because it is highly contagious, transmissible before symptoms appear, and from the data we have so far seems to kill about 1 percent of victims. Federal and provincial governments are coming up with vast sums of borrowed money to counter the health and economic effects of the disease and responses. This contrasts with the usual reaction from governments when asked to pay for new high-cost drugs for cystic fibrosis and other genetic rare disorders, including the new era of cures by gene therapies.

The Canadian Organization for Rare Disorders estimates that 1 in 12 Canadians, two-thirds of whom are children, are impacted by a rare disorder. That’s more than 3 million individuals. Many of these disorders cause early death (e.g. the median survival age of cystic fibrosis sufferers in Canada is 52 which means many die at young ages), mental and physical development issues, severe disability, and pain.

Why do Canadian governments’ reactions to COVID-19 differ from their responses to pleas for access to new drugs that can alleviate the suffering and premature deaths caused by genetic and other rare disorders? First, unlike COVID-19, almost all are not infectious. Second, while more than 3 million Canadians have a rare disorder, few have a particular one and, consequently, can create little political influence.

In contrast, although relatively few have COVID-19 so far, the disease’s wider impact of fear and life disruption is felt by all Canadians. Governments are working diligently to build capacities to rescue patients needing intensive hospital care, including respirators. That is the rescue principle in action. As a compassionate society, most of us support extraordinary efforts to save these lives. Any mismanagement of the situation could not only overwhelm the health system and result in many preventable deaths but also swing elections.

COVID-19 is making all Canadians poorer due to loss of employment and business income, depressed property values, depleted pensions and investments, and the inevitable increased taxation as governments try to reduce the huge debts incurred. The situation is more likely to entrench the federal government in its objective to drastically reduce the cost of new medications for rare disorders, cancer and other life-threatening and debilitating conditions.

In July, new Canadian regulations are to take effect to lower ceiling prices for new medicines. The changes will significantly reduce prices, making Canada less attractive as a country for new drugs and vaccines. Two new drugs for breast cancer have already been withdrawn due to uncertainties created by these changes. Applications for new drugs and new clinical trials have fallen significantly.

Canadians with unmet needs face many barriers to accessing new drugs that could extend their lives and improve their quality of life, or even cure them permanently. Access to essential new medicines can be interrupted and delayed for months, years, or forever by the tortuous processes of regulatory approval, health technology assessment, national price negotiation, and provinces’ reluctance to increase their drug plan budgets by including new medicines in their formularies. The increased indebtedness of federal and provincial governments can only exacerbate the situation.

When a drug developer, using private funding, produces a medicine or vaccine against COVID-19, it will undoubtedly be made available to Canadians. The company will be either generous or shamed into making it available at a low price. Governments can’t embarrass manufacturers of drugs for other rare disorders into lowering prices, so they are trying to force them by regulation, not negotiation, to make harsh price reductions. The methods being applied are heavy-handed and more likely to deter companies from bringing new products to Canada.

The federal government’s failures to act quickly to control borders to reduce COVID-19 carriers entering Canada, to ensure tracking or supervision for 14 days of incubation and to establish comprehensive and rapid testing for the virus will sadly lead to COVID-19 becoming a common disease in Canada very soon. When life eventually returns to some state of normality, Canadians with genetic and other rare disorders who face premature death and disability every day must be provided with access to new medicines that can improve their lives. They need to be rescued too. They must not be left even further out in the cold than they are now.

Nigel Rawson is president of Eastlake Research Group and affiliate scholar with the Canadian Health Policy Institute. John Adams is cofounder and CEO of Canadian PKU and Allied Disorders Inc. and volunteer board chair of Best Medicines Coalition.

 

Tags: COVID-19HealthHealth PolicyJohn AdamsNigel RawsonPharmacare
Previous Post

It’s time to talk about a COVID-19 exit strategy: Rob Wildeboer and Ray Pennings in The Hill Times

Next Post

We need to be thinking about the long-term economic recovery now: Philip Cross’s Testimony to the Federal Finance Committee

Related Posts

Does the cancellation of the Keystone XL pipeline hurt Indigenous people? Yes: Stephen Buffalo in the Toronto Star
Columns

Is Alberta Oil Ethical? Heather Exner-Pirot in Alberta Views

March 31, 2023
Canada’s rising carbon tax, energy prices and the Supreme Court: Andrew Roman for Inside Policy
Inside Policy

Canada’s rising carbon tax, energy prices and the Supreme Court: Andrew Roman for Inside Policy

March 31, 2023
Another found of trade negotiations with the US: How to avoid surprises – Lawrence L. Herman for Inside Policy
Inside Policy

Another found of trade negotiations with the US: How to avoid surprises – Lawrence L. Herman for Inside Policy

March 31, 2023
Next Post
Asleep at the Switch in a Time of COVID-19 Crisis: Shawn Whatley in the Epoch Times

We need to be thinking about the long-term economic recovery now: Philip Cross's Testimony to the Federal Finance Committee

Macdonald-Laurier Institute

323 Chapel Street, Suite #300
Ottawa, Ontario
K1N 7Z2 Canada

613.482.8327

info@macdonaldlaurier.ca
MLI directory

Follow us on

Newsletter Signup

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

Inside Policy Magazine

  • Current Issue
  • Back Issues
  • Advertising
  • Inside Policy Blog
  • Privacy Policy

© 2021 Macdonald-Laurier Institute. All Rights reserved.

No Result
View All Result
  • Home
  • About
    • Who We Are
    • Who Makes MLI Work
    • Tenth Anniversary
    • Jobs
    • Women’s History Month Fundraiser
  • Experts
    • Experts Directory
    • In Memoriam
  • Issues
    • Domestic Policy Program
      • Agriculture and Agri-Food
      • Canada’s Political Tradition
      • Economic policy
      • Health Care
      • Innovation
      • Justice
      • Social issues
      • Telecoms
    • Energy Policy Program
      • Energy
      • Environment
    • Foreign Policy Program
      • Foreign Affairs
      • National Defence
      • National Security
    • Indigenous Affairs Program
  • Projects
    • COVID and after: A mandate for recovery
    • COVID Misery Index
      • Beyond Lockdown
    • Provincial COVID Misery Index
    • Centre for Advancing Canada’s Interests Abroad
      • Dragon at the Door
      • The Eavesdropping Dragon: Huawei
    • An Intellectual Property Strategy for Canada
    • Competition Policy in Canada
    • Speak for Ourselves
    • Canada and the Indo-Pacific Initiative
    • DisInfoWatch.org
    • The Transatlantic Program
    • Indigenous Prosperity at a Crossroads
      • Aboriginal Canada and Natural Resources
    • Talkin’ in the Free World with Mariam Memarsadeghi
    • Past Projects
      • Justice Report Card
      • Munk Senior Fellows
      • A Mandate for Canada
      • Confederation Series
      • Fiscal Reform
      • The Canadian Century project
      • Fixing Canadian health care
      • Internal trade
      • From a mandate for change
      • Size of government in Canada
  • Events
    • Upcoming Events
    • Past Events
      • MLI Dinners
      • Great Canadian Debates
  • Latest News
  • Libraries
    • Annual Reports
    • Inside Policy Magazine
      • Inside Policy Back Issues
      • Inside Policy Blog
    • Papers
    • Columns
    • Books
    • Commentary
    • Straight Talk
    • Video
    • Multimedia
    • Podcasts
    • Leading Economic Indicator
    • Labour Market Report
    • MLI in the Media

© 2021 Macdonald-Laurier Institute. All Rights reserved.